Abiomed Inc. has added to its heart support portfolio with a PMA approval for the Impella RP heart pump for temporary right ventricular support after left ventricular assist device (LVAD) implantation, heart attack, surgery or transplant. The device was previously granted the FDA's humanitarian device exemption.

Technology seems to leap ahead at an astounding pace and is disruptive for many businesses, but is achingly slow for patients who await disease detection and treatments. A recent TED Radio Hour, “Fighting Cancer,” included speakers who addressed their approaches to speeding the move toward more precise and faster-acting cancer diagnostics and targeted therapies. James Bradner of Dana Farber Cancer Institute, and president of Novartis Institutes for Biomedical Research, was part of a research team which shared the molecule they discovered to treat a rare form of cancer publicly. The normal steps after research of protecting the information and developing...

Prellis Biologics has won $1.8 million in seed funding for its 3-D printed tissue technology aimed to create human organs for transplant. The firm intends to surpass the obstacle that has so far delayed organ manufacture by building microvasculature into the tissue.

Coopersurgical has agreed to buy Teva Pharmaceuticals Industries Ltd.'s Paragard intrauterine device (IUD) for $1.1 billion in cash and is expected to close the deal late this year. The acquisition includes Teva's exclusive Paragard manufacturing facility in Buffalo, N.Y., and marks continued effort to divest Teva's global women's health business, according to the company.